uniQure
QURE
#5384
Rank
โ‚น122.24 B
Marketcap
โ‚น1,962
Share price
2.06%
Change (1 day)
217.51%
Change (1 year)

Revenue for uniQure (QURE)

Revenue in 2025 (TTM): โ‚น1.36 Billion

According to uniQure's latest financial reports the company's current revenue (TTM ) is โ‚น1.41 Billion. In 2024 the company made a revenue of โ‚น2.32 Billion an increase over the revenue in the year 2023 that were of โ‚น1.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for uniQure from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น1.36 B-41.47%
2024 โ‚น2.32 B76.39%
2023 โ‚น1.31 B-85.03%
2022 โ‚น8.81 B-77.41%
2021 โ‚น39.00 B1321.59%
2020 โ‚น2.74 B428.4%
2019 โ‚น0.51 B-34.19%
2018 โ‚น0.78 B-5.72%
2017 โ‚น0.83 B-50.76%
2016 โ‚น1.69 B149.48%
2015 โ‚น0.68 B81.55%
2014 โ‚น0.37 B50.83%
2013 โ‚น0.24 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.242 T 228,272.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.96 B 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚น9.37 B 559.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น1.88 B 32.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.284 T 301,627.39%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚น278.90 B 19,543.20%๐Ÿ‡บ๐Ÿ‡ธ USA